Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
SAHPRA Application ID Update 2025: Impact on eCTD Submission and eCTD Publishing The South African Health Products Regulatory Authority (SAHPRA) released an important communication (Issue No.: HPA16-2025/26) introducing a standardized Application ID system that directly impacts eCTD submission, dossier structuring, and eCTD publishing workflows. Th...
In 2001, a small group of life sciences leaders came together with a simple but unconventional idea, to create a space where industry peers could collaborate, benchmark and solve shared challenges. At the time, pharmacovigilance and regulatory environments were fragmented, largely manual and defined by siloed decision-making. Structured, peer-to-pe...
Organizations approaching regulatory approval and commercialization face a rapid expansion in pharmacovigilance requirements, moving from development-focused clinical safety activities to full post-marketing obligations, global reporting, and continuous benefit–risk management. This transition demands strategic advisory to design a fit-for-p...
Biotech Innovation Meets Clinical Trial Excellence Biotech innovation is advancing rapidly but translating breakthroughs into approved therapies remains a challenge. Across biotech clinical trials, sponsors continue to face delays, recruitment bottlenecks and increasingly complex trial designs. These challenges persist in ophthalmology clinical tri...
Turning Regulatory Complexity into Strategic Advantage Hybrid and decentralized models are becoming the default architecture for modern clinical development. Yet, as innovation accelerates, regulatory alignment remains uneven, creating a new layer of complexity for sponsors operating across borders. A recent peer-reviewed publication in The Pharma ...
PHUSE APAC Connect 2026 brought together clinical data leaders, programmers and statisticians from across the region, and Navitas Life Sciences was proud to be part of the conversation. (from left to right) – Sheikh Ibrahim, Pradip Sivaramakrishnan, Swapnil Udasi, Neeraj Malhotra, Anbarasan Durairajan , RamMohan Konda, Rahul Somavanshi. --> W...
What Is Data Management in Clinical Trials? Data management in clinical trials is the structured process of collecting, validating, cleaning, standardizing and preparing clinical trial data for statistical analysis and regulatory submission. How does data management work in clinical trials? In simple terms, clinical data management ensures that tri...
The biopharmaceutical industry is approaching a defining moment. Scientific breakthroughs across cell and gene therapies, precision oncology and novel biologics are accelerating faster than the systems designed to test them. This perspective is informed by recent industry thought leadership, including insights published by McKinsey & Company on...
In an industry defined by scientific complexity, global regulatory shifts and rising expectations for speed and quality, pharma and biotech organizations increasingly rely on life sciences consulting services that offer both strategic foresight and operational depth. Navitas Life Sciences stands apart as a pharma and biotech advisory partner with t...
Patient registries have become one of the most powerful tools Foundations can use to advance research, improve care and amplify the patient voice. They inform real-world evidence generation. They guide standards of care. They influence policy, funding and therapeutic development. And yet, many registries fail quietly. Not because of poor intent or ...